These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors. Allen P; Bragg RA; Caffrey M; Ericsson C; Hickey MJ; Kingston LP; Elmore CS J Labelled Comp Radiopharm; 2017 Feb; 60(2):124-129. PubMed ID: 27868229 [TBL] [Abstract][Full Text] [Related]
7. Tandem Benzophenone Amino Pyridines, Potent and Selective Inhibitors of Human Leukotriene C4 Synthase. Kleinschmidt TK; Haraldsson M; Basavarajappa D; Lundeberg E; Thulasingam M; Ekoff M; Fauland A; Lehmann C; Kahnt AS; Lindbom L; Haeggström JZ J Pharmacol Exp Ther; 2015 Oct; 355(1):108-16. PubMed ID: 26283693 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14. Šamonina-Kosicka J; Kańska M J Labelled Comp Radiopharm; 2013 May; 56(6):317-20. PubMed ID: 24285411 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of tritium labeled 30-KDa PEG and conjugation to form [ Easter JA; Tian Y; Burrell RC; Hong Y; Bonacorsi SJ J Labelled Comp Radiopharm; 2021 Oct; 64(12):477-481. PubMed ID: 34386991 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficiency of Pd/H2 -catalyzed benzylic H/D exchange of dehydroabietinal with D(2) O and synthesis of a tritium-labeled analogue. Petros RA; Shah J J Labelled Comp Radiopharm; 2014 Jan; 57(1):53-6. PubMed ID: 24448746 [TBL] [Abstract][Full Text] [Related]
12. Development of smart cell-free and cell-based assay systems for investigation of leukotriene C Liening S; Scriba GK; Rummler S; Weinigel C; Kleinschmidt TK; Haeggström JZ; Werz O; Garscha U Biochim Biophys Acta; 2016 Nov; 1861(11):1605-1613. PubMed ID: 27477678 [TBL] [Abstract][Full Text] [Related]
13. A leukotriene C4 synthase inhibitor with the backbone of 5-(5-methylene-4-oxo-4,5-dihydrothiazol-2-ylamino) isophthalic acid. Ago H; Okimoto N; Kanaoka Y; Morimoto G; Ukita Y; Saino H; Taiji M; Miyano M J Biochem; 2013 May; 153(5):421-9. PubMed ID: 23378248 [TBL] [Abstract][Full Text] [Related]
14. Enzymatic syntheses of 3'-halotyramines, selectively Pająk M; Kańska M Appl Radiat Isot; 2018 Jan; 131():8-12. PubMed ID: 29080428 [TBL] [Abstract][Full Text] [Related]
15. Recent Developments for the Deuterium and Tritium Labeling of Organic Molecules. Kopf S; Bourriquen F; Li W; Neumann H; Junge K; Beller M Chem Rev; 2022 Mar; 122(6):6634-6718. PubMed ID: 35179363 [TBL] [Abstract][Full Text] [Related]
16. A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines, and Pharmaceuticals. Koniarczyk JL; Hesk D; Overgard A; Davies IW; McNally A J Am Chem Soc; 2018 Feb; 140(6):1990-1993. PubMed ID: 29377684 [TBL] [Abstract][Full Text] [Related]
17. Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1 Munck Af Rosenschöld M; Johannesson P; Nikitidis A; Tyrchan C; Chang HF; Rönn R; Chapman D; Ullah V; Nikitidis G; Glader P; Käck H; Bonn B; Wågberg F; Björkstrand E; Andersson U; Swedin L; Rohman M; Andreasson T; Bergström EL; Jiang F; Zhou XH; Lundqvist AJ; Malmberg A; Ek M; Gordon E; Pettersen A; Ripa L; Davis AM J Med Chem; 2019 Sep; 62(17):7769-7787. PubMed ID: 31415176 [TBL] [Abstract][Full Text] [Related]
18. The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders. Bragg RA; Bushby N; Ericsson C; Kingston LP; Ji H; Elmore CS J Labelled Comp Radiopharm; 2016 Sep; 59(11):454-61. PubMed ID: 27558079 [TBL] [Abstract][Full Text] [Related]